about
Quetiapine safety in older adults: a systematic literature review.Medication Adherence in Older Patients With Dementia: A Systematic Literature Review.The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.Glucarpidase for the treatment of life-threatening methotrexate overdose.Value of information analysis in oncology: the value of evidence and evidence of value.Value of information analysis in healthcare: a review of principles and applications.Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.Setting Medical Research Future Fund priorities: assessing the value of research.A Program to Increase Research Productivity Among Hospital Pharmacists.How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia.Cost-effectiveness Analysis of Nutritional Support for the Prevention of Pressure Ulcers in High-Risk Hospitalized Patients.Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective.Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds.Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.Novel technologies can provide effective dressing and securement for peripheral arterial catheters: A pilot randomised controlled trial in the operating theatre and the intensive care unit.Health Care and Pharmacy Practice in Jordan.Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor.Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters.Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: collection effectiveness and cost effectiveness analysis.Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised PatientsThe epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save?Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for fundingNew challenges in psycho-oncology: Economic evaluation of psychosocial services in cancer: Challenges and best practice recommendationsInternational HTA Experience with Targeted Therapy Approvals for Lung Cancer.Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions.Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer centerRevision and validation of a medication assessment tool for chronic cancer pain managementThe Australian Managed Entry Scheme: Are We Getting it Right?Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation TherapyDressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trialCost of vascular access devices in public hospitals in QueenslandAdaptations to cognitive problems reported by breast cancer survivors seeking cognitive rehabilitation: A qualitative studyIncidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature reviewA Framework to Prioritise Health Research Proposals for Funding: Integrating Value for Money
P50
Q35905294-12736CE6-9E2E-4AD8-8D93-6746C519D18BQ36379356-947C243A-77F7-4292-9A36-734BF9AF2C38Q37182159-89A68950-8C7C-42CD-ABCE-A54612F7A664Q38061431-7B07A124-4E2E-4900-A2EF-F6D53464BF7DQ38160210-14186166-5198-4350-868C-F2B643CB2781Q38197696-9BA01FF0-DB26-4F63-9FBD-ECD0A0A482F1Q38343692-10CA2035-9AA9-485D-8F44-0B8B634855E8Q38762782-BC755C91-1B16-44E8-8096-596C8686BC11Q38817120-0A49B595-FA0B-4D7E-854C-085303A9C1D4Q38824531-5A3E9B07-176A-4FB7-9A73-1D247FC32DF3Q38832725-2006D8BF-5C19-488E-826F-BC11A1383AB0Q38871461-62399634-1DB0-4C55-A18B-EE85A85760EFQ39026759-8B136E16-0573-4A63-A792-71C8451F5EEAQ39149842-0DCFB51F-2AA9-4E41-BA4B-889DD7452173Q41547690-094F92AD-B612-4A18-BB80-E004B1469BADQ42290359-DD56EC60-2B86-4E7D-83F6-E53D437900C6Q42780823-CA285FB8-D8B4-4918-970B-B0E6B3DA80BEQ47646760-D1979712-F82A-40E4-B69F-57EA6B66B7B0Q49708753-404A555A-E108-40A8-8E1C-A0FDD4570AE6Q50134096-470C3EFE-3A0E-4442-8FA1-55BA556224BAQ50195463-5DAB760E-D8C7-4CED-851C-627F6A6926A1Q50991995-21C56B82-89C9-44B8-9EC2-294D9762A634Q57574196-63BA63E5-D97F-4EAB-A681-2B914678294AQ57574222-91B1021E-3670-438C-859F-A81FF3541471Q60936270-F6FFB63E-1512-4DFD-9877-EAC34927C9C7Q63363874-0F1FCDC8-27D5-46E9-8E90-3D59E365BD73Q64884401-3A8E075A-5B38-486A-9C89-E95641BB8F4EQ64963591-572AF4EC-84A8-4F77-9B86-98A403B782D1Q83154013-2248A683-5858-43E0-80BB-35900ED00E24Q83395934-9862749E-A07E-497A-A55C-6874A43090EAQ87871400-185AE9E3-F581-4E63-873C-0BF629E5A065Q89928432-B25A85EA-DF79-428C-80A0-12F3D500D7B8Q90596768-18756C84-89A0-43EE-98A0-6497CB85FE65Q91274023-99317CC4-7ACF-4732-BF9F-90136D49500AQ92303849-4DDB8EBD-E146-41B6-9F59-4AD522162B79Q92485220-173DA444-7625-481F-BAD7-F4C9467512DBQ93140809-28E8EEE3-1C20-4EAF-9644-21C0A548D8A0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Haitham W Tuffaha
@ast
Haitham W Tuffaha
@en
Haitham W Tuffaha
@es
Haitham W Tuffaha
@nl
type
label
Haitham W Tuffaha
@ast
Haitham W Tuffaha
@en
Haitham W Tuffaha
@es
Haitham W Tuffaha
@nl
prefLabel
Haitham W Tuffaha
@ast
Haitham W Tuffaha
@en
Haitham W Tuffaha
@es
Haitham W Tuffaha
@nl
P106
P1153
25958756000
56181162200
P31
P496
0000-0003-2993-3480